Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Welcome to the P&T Committee: Reining in Biotech Prices

This article was originally published in RPM Report

Executive Summary

Biotech companies have long enjoyed relative freedom from managed care cost containment. But one MCO executive--WellPoint's Chief Pharmacy Officer Robert Seidman--says the party is just about over. WellPoint's plans for the human growth hormone class once Sandoz' Omnitrope hits the market is one example of what biotech has to look forward to.

You may also be interested in...



The Avastin Dilemma: Two Personalities and Two Points of View on Cost Effectiveness

Two of the key figures in the 2009 health reform debate, Zeke Emanuel and Billy Tauzin, each use Genentech's Avastin to demonstrate the importance of doing cost effectiveness right. But they look at the same drug from very different points of view. Their perspectives provide a good guide to what is at stake in the design of federal approach to comparative effectiveness research.

Experimental Cost Controls: Plans Moving Doctor-Administered Drugs From Medical To Pharmacy Benefit

Experimental Cost Controls: Plans Moving Doctor-Administered Drugs From Medical To Pharmacy Benefit

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

PS080118

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel